<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230907059376N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-13</date_registration>
      <primary_sponsor>Afridi Medical Complex, Peshawar</primary_sponsor>
      <public_title>Controlled decompression effects in the patients with severe TBI: A Randomized Control Trial</public_title>
      <acronym></acronym>
      <scientific_title>Controlled decompression effects in the patients with severe TBI:  A Randomized Control Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-08-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72532</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In our trial, randomization was conducted using a computer-generated random sequence that allocated participants into one of two groups: controlled decompression or fast decompression, following Traumatic Brain Injury (TBI) prior to surgery. This randomization process ensured that each participant had an equal and unbiased chance of being assigned to either group, minimizing potential selection bias and allowing for a more reliable assessment of the treatment outcomes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Traumatic brain injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Standard surgical techniques were used to achieve a rapid craniotomy.The dura was entirely opened by a normal large craniotomy (12 to 15 cm), allowing the ICP to be quickly, totally, and uncontrollably discharged. ICP monitoring was given to each patient in this group. The intraoperative surgical approach did not take the ICP into account, and the rate of ICP decline was not managed during the procedure. The fast removal of the hematoma and brain contusion tissue was the main objective of the procedure. Intervention 2: Control group: The goal of controlled decompression was to guarantee that the ICP would gradually release over the whole treatment using a variety of techniques. ICP dropped at a rate of 10-15 mmHg per 10 minutes. Before the craniotomy, an ICP probe was implanted to get the initial ICP. The best option was a brain tissue monitor, followed by a ventricular intracranial pressure monitor. Cerebrospinal fluid (CSF) was gradually discharged until the ICP was &gt; 40 mmHg if the initial ICP was greater than that value. Second, to pressurize the brain and prevent a sharp drop in ICP after the bone was removed, a craniotomy with a bone window (12 ×15 cm) was necessary. Third, a small incision no bigger than 5 mm, which is frequently the diameter of the aspirator head, was used to breach the dura. The ICP was steadily decreased while the hematoma and brain contusion tissue were carefully aspirated. The dura was completely opened, and the hematoma or brain contusion tissue was then removed when the ICP was less than 10 mmHg and there were no visible evidence of bulging brain tissue.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Controlled decompression effects in the patients with severe TBI: 
A Randomised Control Trial

When:
Next year

To whom:
Neuro surgeon

Conditions:
Through email

Where to obtain:
Contacting Principal author through email

How to obtain:
Contact Principal author Dr Mhaboob through email. 
Email of the author is: mehbob509@gmail.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Abdul Hameed Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sharoe Green Ln, Fulwood, Preston PR2 9HT, UK</address>
        <city>Preston</city>
        <country1>United Kingdom of Great Britain and Northern Ireland</country1>
        <zip>PR2 9HT</zip>
        <telephone>+44 1772 716565</telephone>
        <email>drhameedkhan@gmail.com</email>
        <affiliation>Royal Preston Hospital, Preston UK</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahboob Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Afridi medical complex tehkal payan, University Rd, Tehkal, Peshawar, Khyber Pakhtunkhwa</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25150</zip>
        <telephone>+92 91 5711751</telephone>
        <email>mehboob509@gmail.com</email>
        <affiliation>Afridi Medical Complex, Peshawar</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with TBI between the ages of 18 and 75
Patients who gave informed permission
Glasgow Coma Scale (GCS) score between 3 and 8 at admission</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Initial need for bilateral craniotomy
Preoperative GCS score of 3 with no improvement after treatment in the emergency room
Presentation without attenuated respiration and blood pressure
Combination of anoxia and hypotension with brain swelling caused by anoxia or hypotension and minor intracranial bleeding after injury
Coagulation disorder or a history of aspirin intake and multiorgan malfunction</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S06.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diffuse traumatic brain injury</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Standard surgical techniques were used to achieve a rapid craniotomy.The dura was entirely opened by a normal large craniotomy (12 to 15 cm), allowing the ICP to be quickly, totally, and uncontrollably discharged. ICP monitoring was given to each patient in this group. The intraoperative surgical approach did not take the ICP into account, and the rate of ICP decline was not managed during the procedure. The fast removal of the hematoma and brain contusion tissue was the main objective of the procedure.</i_keyword>
      <i_keyword>Control group: The goal of controlled decompression was to guarantee that the ICP would gradually release over the whole treatment using a variety of techniques. ICP dropped at a rate of 10-15 mmHg per 10 minutes. Before the craniotomy, an ICP probe was implanted to get the initial ICP. The best option was a brain tissue monitor, followed by a ventricular intracranial pressure monitor. Cerebrospinal fluid (CSF) was gradually discharged until the ICP was &gt; 40 mmHg if the initial ICP was greater than that value. Second, to pressurize the brain and prevent a sharp drop in ICP after the bone was removed, a craniotomy with a bone window (12 ×15 cm) was necessary. Third, a small incision no bigger than 5 mm, which is frequently the diameter of the aspirator head, was used to breach the dura. The ICP was steadily decreased while the hematoma and brain contusion tissue were carefully aspirated. The dura was completely opened, and the hematoma or brain contusion tissue was then removed when the ICP was less than 10 mmHg and there were no visible evidence of bulging brain tissue.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Global disability and recovery after traumatic brain injury. Timepoint: Baseline and after 6 months. Method of measurement: Extended Glasgow Outcome Scale (GOSE).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Afridi Medical Complex, Peshawar</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-13</approval_date>
        <contact_name>Afridi Medical Complex ethical committee</contact_name>
        <contact_address>Afridi medical complex tehkal payan, University Rd, Tehkal, Peshawar, Khyber Pakhtunkhwa Peshawar Khyber Pakhtunkhwa Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
